Czechia· CZ-0272454
OBGEMSA
A vibegron product containing vibegron, registered in Czechia by PIERRE FABRE MEDICAMENT, Lavaur. The same ATC class is registered in 13 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Vibegron is registered in 13 of 19 countries.
Countries holding a registration under ATC G04BD15 (vibegron), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 9 of them publish a price we can compare per daily dose
Vibegron · ATC G04BD15
13 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of vibegron costs, country by country.
Normalised to the WHO defined daily dose (75 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Vibegron · price per daily dose (75 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.76
The record
At a glance
SÚKL (Czech Republic)- Active substance
- VIBEGRON
- Manufacturer
- PIERRE FABRE MEDICAMENT, Lavaur
- Country
- Czechia (CZ)
- ATC code
- G04BD15
- ATC class
- Vibegron
- Defined daily dose
- 75 mg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for vibegron.
Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Vibegron · interactions on record
2 records
- 2 moderate
Most severe, free to view
- TrospiumA03AB20moderate
- TrospiumG04BD09moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Vibegron in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandObgemsa 75 mg, FilmtablettenPierre Fabre Pharma SA
- FinlandObgemsaPierre Fabre Medicament
- FranceOBGEMSA 75 mg, comprimé pelliculéPIERRE FABRE MEDICAMENT
- IrelandObgemsa 75 mg film-coated tabletsPierre Fabre Medicament
- IcelandObgemsaPierre Fabre Medicament
- NetherlandsObgemsa 75 mg filmomhulde tablettenPierre Fabre Medicament
- NorwayObgemsaPierre Fabre Medicament
- PolandObgemsaPierre Fabre Medicament
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Obgemsa
- Liechtenstein · Obgemsa
- Norway · Obgemsa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bab64382-79ec-4bc9-bed7-ad693bbe6b87 GET /v1/drugs/bab64382-79ec-4bc9-bed7-ad693bbe6b87?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL FLM",
"source": "sukl",
"strength": "75MG",
"pack_size": "7 I",
"substance": "VIBEGRON",
"cz_kod_sukl": "0272454",
"product_type": "CH",
"substance_codes": "20107",
"registration_state": "R",
"registration_number": "EU/1/24/1822/001"
}See everything about vibegron.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.